pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
CD19 · news · pharmadog
← back to CD19
News · CD19
12
stories
2d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
7d
After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
fiercebiotech
9d
Boulevard starts up with $65M to pursue targeted autoimmune drugs
biopharma dive
10d
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
fiercebiotech
22d
J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout
fiercebiotech
23d
Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy
biospace
25d
Legend Biotech CEO abruptly steps down without permanent replacement
fiercebiotech
25d
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
biospace
29d
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
Jun 3, 26
Legend surges on early data for ‘in vivo’ lymphoma cell therapy
biopharma dive
May 14, 26
Create Medicines raises $122M to bolster in vivo CAR-T therapies
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
fiercebiotech
